Panacea Acquisition Corp
Completed
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $125M
- Underwriters
- Focus
- Biotech
- SEC Filings
- 1811063
- Public Embarc Page
- https://embarc.com/capital/spac/1811063/PANA/panacea-acquisition
- IPO Ticker
- PANA
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and ChairmanOleg Nodelman
- Chief Financial OfficerScott Perlen
- Chief Operating OfficerScott Platshon
- Chief Investment OfficerCaroline Stout
- DirectorDaniel Bradbury
- DirectorGraham Cooper
- DirectorFaheem Hasnain
- Secretary and DirectorSarah Marriott
- DirectorShalini Sharp
Target Information
Information on the SPAC target for merger.
- Company
- Nuvation Bio
- Presentation
- Investor Presentation (SEC) on 2021-01-05
- Description
- Nuvation Bio is a biopharmaceutical company focused on cancer treatment by discovering, developing, and delivering oncology therapies.